[1] | Yuan WANG, Huaie LIU, Jie DING, Qingqing WANG, Aili WANG, Hui SUN, Hui CAO. Role of new serological markers in evaluating the progression of liver disease in patients with chronic HBV infection and normal aminotransferases[J]. Journal of Clinical Hepatology, 2023, 39(3): 644-650. doi: 10.3969/j.issn.1001-5256.2023.03.026 |
[2] | Jiang YingYing, Zheng SuJun. Research advances in predictive markers for HBeAg seroconversion in chronic hepatitis B patients treated with nucleos( t) ide analogues[J]. Journal of Clinical Hepatology, 2020, 36(6): 1358-1361. doi: 10.3969/j.issn.1001-5256.2020.06.036 |
[3] | Li Qiang, Huang YuXian, Chen Liang. Independent predictive factors for significant liver histological changes in patients with HBe Ag-positive high-viral-load chronic HBV infection and a normal alanine aminotransferase level[J]. Journal of Clinical Hepatology, 2016, 32(7): 1310-1314. doi: 10.3969/j.issn.1001-5256.2016.07.019 |
[4] | Cao ZhenHuan, Liu YaLi, Ma LiNa, Lu JunFeng, Jin Yi, He ZhiMin, Zheng YanHong, Chen XinYue. Association between serum level of interleukin-17 and HBsAg clearance in patients with HBsAg-negative chronic hepatitis B[J]. Journal of Clinical Hepatology, 2016, 32(7): 1292-1295. doi: 10.3969/j.issn.1001-5256.2016.07.015 |
[5] | Xian YongChao, Cheng ShuQuan, Ni Hui, Huang ChengJun. Analysis of hepatic CD4~+,CD8~+,CD20~+,and CD57~+ T lymphocytes in chronic hepatitis B patients with different HBe Ag status[J]. Journal of Clinical Hepatology, 2015, 31(4): 546-550. doi: 10.3969/j.issn.1001-5256.2015.04.017 |
[6] | Wang Fei, Xu AiLing, Xin XiaXia, Yuan Hong, Xiong JingJing, Zhang Qi, Wang Chen. Relationship between e system of hepatitis B and HBV DNA quantification[J]. Journal of Clinical Hepatology, 2015, 31(4): 534-536. doi: 10.3969/j.issn.1001-5256.2015.04.014 |
[7] | Lan Lin, Kong Yin, Zhang LingYi. Significance of changes in hepatic histology from patients with HBe Ag( + ) or HBe Ag(-) chronic hepatitis B and normal or mildly elevated alanine aminotransferase[J]. Journal of Clinical Hepatology, 2015, 31(4): 510-513. doi: 10.3969/j.issn.1001-5256.2015.04.008 |
[8] | Zhou LianLian, Shen Mo, Zhou Ping, Zhou Wu, Lin XiangYang. HBV genotype distribution and its relationship with serum HBV DNA level and HBeAg expression among patients with chronic hepatitis B in southern Zhejiang Province, China[J]. Journal of Clinical Hepatology, 2014, 30(10): 1039-1041. doi: 10.3969/j.issn.1001-5256.2014.10.016 |
[9] | Zheng DongChun, Nie YuanXia, Liang HaiLin, Hu YueLin, Cheng Xiao, Feng XiaoXia, Chen YongPing. Epidemiological features and serological changes in sporadic acute hepatitis B among adults: an analysis of 202 cases[J]. Journal of Clinical Hepatology, 2014, 30(1): 30-33. doi: 10.3969/j.issn.1001-5256.2014.01.009 |
[10] | Liu XingXiang, Li GuiZhen, Xu YunFang, Zhang Jing. Relationship between HBV DNA and HBeAg in serum and HBcAg and inflammation grade in liver tissue among patients with chronic hepatitis B[J]. Journal of Clinical Hepatology, 2013, 29(12): 919-921. doi: 10.3969/j.issn.1001-5256.2013.12.011 |
[11] | Wu YinYa, Tan ShanZhong, Zhao Lei, Sun WeiWei, Shen JianJun, Liang ZhongFeng. The changes and value of the proportion of CD4+CD25+ regulatory T cells in HBeAg (+) and HBeAg (-) ASC in peripheral blood[J]. Journal of Clinical Hepatology, 2012, 28(3): 209-211. |
[12] | Gao Min, Lu ChengZhen, Wang Yi, Zhai Lu, Guo Jie, Zhou Li, Han Xu, Liu YongGang, Cao Li. Relationship between expression of HBcAg in liver tissue and characteristics of the hepatic pathological features in patients with chronic hepatitis B virus infection[J]. Journal of Clinical Hepatology, 2012, 28(3): 201-204. |
[13] | Wu YuZhuo. Correlation analysis of quantitative HBsAg and liver histological features of HBeAg-negative chronic hepatitis B patients[J]. Journal of Clinical Hepatology, 2012, 28(12): 923-925. |
[14] | Ren Shan, Huang YanXiang, Ma LiNa, Jin Yi, He ZhiMin, Zhang XiaoDan, Chen XinYue. The association study of the polymorphisms of interferon-inducible genes OAS and the seroconversion of HBsAg and HBeAg in patients with HBeAg positive chronic hepatitis B infection receiving interferon-αand nucleotide analogue combined therapy[J]. Journal of Clinical Hepatology, 2011, 27(12): 1270-1274. |
[15] | Yao QinJiang, Ma WeiGuo. Therapeutic efficacy of telbivudine in hepatitis B e antigen positive chronic hepatitis B patients with high baseline alanine aminotransferase levels[J]. Journal of Clinical Hepatology, 2011, 27(6): 614-616. |
[16] | Liang YanXiu, Jiang JianNing, Su MingHua, Guo WenWen, Huang XiaoHong, Liu ZhiHong, Xie Rong, Fu WuDao, He LiXia, Zhong ShaoHua. Influence of HBeAg seroconversion on virological relapse in chronic hepatitis B patients on withdrawal of nucleos (t) ide analogues therapy[J]. Journal of Clinical Hepatology, 2011, 27(12): 1275-1277+1290. |
[17] | Tan YiYun, Shen HuiGuo, Zheng YingJie, Wang Na, Lu YiHan, Jiang QingWu, Gao MeiYang. Analyze the diagnosis of acute viral hepatitis based on serial serum[J]. Journal of Clinical Hepatology, 2008, 24(6): 415-416. |
[18] | Ou XiaoJuan, Wang XiaoMing, Wang BaoEn, Wang TaiLing, Ma Hong, You Hong, Jia JiDong. Reevaluation of diagnostic value of serum fibrosis markers to liver fibrosis staging in patients with chronic hepatits B[J]. Journal of Clinical Hepatology, 2007, 23(6): 413-414. |